Director and Head of Investor Relations
Phone - Direct: +46 8 587 254 15
As pioneers of future technology, Elekta is setting a new standard of cancer care once again with magnetic resonance radiation therapy (MR/RT).
MR/RT addresses an unmet need in cancer therapy, enabling clinicians to confidently see and track difficult to visualize soft-tissue anatomies.
Head of Investor Relations (interim)
Phone - Direct: +46 707638125
gunilla.oehman (a) elekta.com
Executive Vice President, Corporate Communications & IR Phone - Direct: +46 704107180
Oskar.Bosson (a) elekta.com
Executive Vice President, Corporate Communications & IR